术前口服地西泮用于球后神经阻滞麻醉下玻璃体切除术高血压患者术中血压稳定:随机对照试验研究方案
本研究为单中心、双盲、随机对照平行临床试验,计划纳入180例在球后神经阻滞麻醉下接受玻璃体切除术的高血压患者,按1:1随机分为术前口服地西泮组和口服安慰剂组,主要结局为术中血压控制有效率(术中所有时间点收缩压<160mmHg),以逻辑回归比较组间差异。
要点
- 拟纳入180例高血压玻璃体切除术患者,随机分为地西泮组与安慰剂组。
- 主要结局为术中所有时间点收缩压<160mmHg的有效率。
- 次要结局包括术中至术后1小时收缩压≥180mmHg比例及12周内不良反应。
核心结论
- 该研究将评估地西泮在神经阻滞麻醉下高血压患者术中血压稳定中的有效性和安全性。
- 若试验结果有统计学意义,可设计大规模多中心临床试验。
研究设计与样本
- 单中心、双盲、随机对照平行临床试验,计划纳入180例在球后神经阻滞麻醉下接受玻璃体切除术的高血压患者。
- 参与者按1:1比例随机分配至干预组(术前口服地西泮)和对照组(术前口服安慰剂)。
- 采用逻辑回归模型比较结局。
主要发现
- 主要结局为术中血压控制有效率,即术中所有时间点收缩压维持<160mmHg。
- 次要结局包括术中至术后1小时任一时刻收缩压≥180mmHg的患者比例、术中平均收缩压和平均心率较基线的变化,以及术后12周内术中及术后不良反应患者数。
关键数值与推荐
- 术中所有时间点收缩压<160mmHg定义为血压控制有效。
- 术中至术后1小时任一时刻收缩压≥180mmHg为次要结局指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As a type of local anaesthesia, retrobulbar nerve block is often used in vitrectomy, with patients remaining conscious during the operation. The increase in systolic blood pressure (SBP) caused by tension and fear during the operation-especially in patients with a history of hypertension-can negatively impact the safety of the procedure, resulting in suprachoroidal haemorrhage or retinal haemorrhage. Diazepam has a sedative effect and can relieve tension during surgery. This study aims to evaluate the efficacy and safety of diazepam for intraoperative BP stabilisation in hypertensive patients under retrobulbar anaesthesia during surgery. METHODS: This single-centre, double-blind, randomised controlled and parallel clinical trial will include 180 hypertensive patients who will undergo vitrectomy with nerve block anaesthesia. Study participants will be randomly allocated in a 1:1 ratio to intervention (patients receiving oral diazepam before the operation) and control (patients receiving oral placebo before the operation) groups. The primary outcome is the effective rate of intraoperative BP control (systolic BP during operation maintained at <160mmHg at all timepoints). The secondary outcomes are the proportion of patients with SBP ≥180 mmHg at any timepoint from operation to 1 h post-operation, the change of mean systolic blood pressure and mean heart rate during operation from baseline, as well as the number of patients with intraoperative and post-operative adverse reactions within 12 weeks of surgery. The logistic regression model will be performed to compare the outcomes. DISCUSSION: This study will evaluate the efficacy and safety of diazepam for intraoperative BP stabilisation in hypertensive patients under nerve block anaesthesia during surgery. The results of this trial will reveal whether diazepam has a significant effect on intraoperative BP stability in patients with a history of hypertension who require vitrectomy. If the results of this trial are significant, a large-scale multi-centre clinical trial can be designed. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR) ChiCTR2100041772 . Registered on 5 January 2021.
引用
- Qian T, Gong Q, Chen C, et al. Preoperative oral diazepam for intraoperative blood pressure stabilisation in hypertensive patients undergoing vitrectomy under retrobulbar nerve block anaesthesia: study protocol for a randomised controlled trial. Trials. 2022. PMID: 36056369. doi:10.1186/s13063-022-06686-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。